Trials / Completed
CompletedNCT00209950
A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia
A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia
Detailed description
To evaluate long-term safety of gaboxadol in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gaboxadol |
Timeline
- Start date
- 2004-07-01
- Completion
- 2005-09-01
- First posted
- 2005-09-21
- Last updated
- 2007-03-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00209950. Inclusion in this directory is not an endorsement.